HealthEquity, Inc. (HQY) Q3 2026 Earnings Name December 3, 2025 4:30 PM EST
Firm Members
Richard Putnam – Vice President of Investor Relations
Scott Cutler – CEO, President & Director
Stephen D. Neeleman – Founder & Vice Chairman
James Lucania – CFO & Govt VP
Convention Name Members
Stanislav Berenshteyn – Wells Fargo Securities, LLC, Analysis Division
Allen Lutz – BofA Securities, Analysis Division
George Hill – Deutsche Financial institution AG, Analysis Division
Mark Marcon – Robert W. Baird & Co. Integrated, Analysis Division
Brian Tanquilut – Jefferies LLC, Analysis Division
Sean Dodge – BMO Capital Markets Fairness Analysis
Scott Schoenhaus – KeyBanc Capital Markets Inc., Analysis Division
Steven Valiquette – Mizuho Securities USA LLC, Analysis Division
Charles Peters – Raymond James & Associates, Inc., Analysis Division
David Roman – Goldman Sachs Group, Inc., Analysis Division
David Larsen – BTIG, LLC, Analysis Division
Presentation
Operator
Good day, and welcome to the HealthEquity Third Quarter 2026 Earnings Name. [Operator Instructions] Please observe this occasion is being recorded. I might now like to show the convention over to Richard Putnam. Please go forward.
Richard Putnam
Vice President of Investor Relations
Thanks, Dave. Hey, everybody. Thanks for becoming a member of us this afternoon. That is HealthEquity’s Third Quarter Fiscal 12 months 2026 Earnings Convention Name. My identify is Richard Putnam. I do Investor Relations for HealthEquity. Becoming a member of me as we speak are Scott Cutler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founding father of the corporate; and James Lucania, Govt Vice President and CFO. Earlier than I flip the decision over to Scott for ready remarks, we observe {that a} press launch saying our third quarter monetary outcomes was issued after the market closed this afternoon and that it included sure non-GAAP monetary measures that we’ll reference right here as we speak.
You’ll find a duplicate of as we speak’s press launch, together with reconciliation of those non-GAAP measures with comparable GAAP measures
